Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02543463Not ApplicableCompleted

Navigation With X3 vs Non-Navigation With X3 Study

Role: lead

NCT02543437Not ApplicableUnknown

Large Head X3 Study

Role: lead

NCT02552069Unknown

Tritanium® Study in Japan

Role: lead

NCT02552082Completed

Scorpio Non Restricted Geometry (NRG) Study in Japan

Role: lead

NCT02543489Not ApplicableUnknown

Flex Intramedullary Rod Study

Role: lead

NCT02552095Not ApplicableCompleted

Triathlon PKR Study in Japan

Role: lead

All 6 trials loaded